We welcome the European Commission call to improve current access to innovative medicines across the European Union. Following the EFPIA report on the root causes of unavailability and delays of innovative medicines we acknowledge causes are multifactorial and as a pharmaceutical company, we play a role in this.
Astellas
Company · Belgium · EU Transparency Register 726065718920-12
Counts here are a floor, never a total: they cover the 583 consultation files tracked so far (42,224 submissions, mostly 2025–26), so an organization's real filing history is larger, not smaller.
Who they are
Among the 1048 companies & groups on this site, they rank #712 by legislative files engaged — a count of participation, not a measure of influence.
Declares membership of
- The Alliance for Regenerative Medicines https://alliancerm.org/
- The European Federation of Pharmaceutical Industry https://www.efpia.eu/
- the Japan Business Council in Europe https://www.jbce.org/en/
- EUCOPE European Confederation of Pharmaceutical Entrepreneurs https://www.eucope.org
- The European Business Council
Self-declared to the EU Transparency Register (snapshot 2 Sept 2026).
- Register category
- Companies & groups
- Registered as
- Astellas Pharma Europe Limited (APEL)
- Head office
- Addlestone, United kingdom
Self-declared to the EU Transparency Register (snapshot 2 Sept 2026); cost bands are floors, not audited totals. Reused under Commission Decision 2011/833/EU.
Track Astellas in PolicySpeak: request access →
Work at Astellas? so we know who speaks for it.
Their record over time
Astellas filed 1 position on 26 Apr 2021, across 1 of the 583 legislative files tracked here, attaching a full position paper 1 time.
What they argued
Looking for an argument rather than an organization? Search every submission for a phrase and see everyone who used it.
Put Astellas next to another organization. Same files, same register facts, side by side. Compare →
Is this your organization?
Everything on this page comes from Astellas’s own submissions to the European Commission — we have added nothing and interpreted nothing. If something is wrong or out of date, email info@policyspeak.com and we will correct it. If you are an individual named in a record, our privacy policy sets out your rights to correction, objection and removal.
Quotes are verbatim from submissions published by the European Commission, trimmed to their opening passage and never summarized by a model. Organizations only, never individuals. Reused under Commission Decision 2011/833/EU; the European Commission is not liable for this reuse.